FIELD: veterinary medicine.
SUBSTANCE: solution of urotensin 2 is administered subcutaneously 25 mcg/kg in 2-3 ml of 0.9% sodium chloride daily to females for two days, and to males for three days running.
EFFECT: use of invention enables females on the third day, and males on the fourth day of treatment to come into play, to perform commands previously learned.
1 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF DIAGNOSING UROTENSIN-2-DEPENDENT STERILITY IN VERTEBRATE ANIMALS AND PEOPLE | 2012 |
|
RU2500341C1 |
| METHOD FOR REDUCING AND MANAGING BRONCHIAL ASTHMA STATUS | 2012 |
|
RU2503456C1 |
| VERSION OF THE METHOD FOR PREVENTING AND TREATING INDIVIDUALS SUFFERING FROM ESTROGEN-AND ANDROGEN-DEPENDENT TUMORS | 2014 |
|
RU2597779C2 |
| METHOD FOR PREPARING ANTISERUM AGAINST MAMMAL CAUDAL NEUROSECRETORY SYSTEM (CNSS)PEPTIDES | 2003 |
|
RU2272650C2 |
| AGENT FOR INTERRUPTION OF SEXUAL HEAT IN CAT FEMALE "ANTIMEWING" | 1992 |
|
RU2015698C1 |
| METHOD OF PROPHYLAXIS AND TREATMENT OF PATIENTS SUFFERING WITH ESTROGEN- AND ANDROGEN-DEPENDENT TUMORS | 1997 |
|
RU2163812C2 |
| METHOD FOR OBTAINING BIOLOGICALLY ACTIVE PEPTIDES OF CAUDAL NEUROSECRETORY SYSTEM (CNSS) IN VERTEBRATES | 2001 |
|
RU2224528C2 |
| AGENT FOR IMPROVING REPRODUCTIVE FUNCTION | 2012 |
|
RU2487705C1 |
| AGENT FOR IMPROVING REPRODUCTIVE FUNCTION | 2012 |
|
RU2489142C1 |
| RADIOPAQUE PREPARATION | 2011 |
|
RU2448732C1 |
